REFERENCES

• Arahata, K and Engel, AG. Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol. 1986; 19:112-125.
• Auerbach, A, Fanburg-Smith, JC, Wang, G, et al. Focal myositis: a clinicopathologic study of 115 cases of an intramuscular mass-like reactive process. Am J Surg Pathol. 2009; 33:1016-1024.
• Balci, B, Uyanik, G, Dincer, P, et al. An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene. Neuromuscul Disord. 2005; 15:271-275.
• Beckmann, JS and Spencer, M. Calpain 3, the ”gatekeeper” of proper sarcomere assembly, turnover and maintenance. Neuromuscul Disord. 2008; 18:913-921.
• Belaya, K, Finlayson, S, Slater, CR, et al. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates. Am J Hum Genet. 2012; 91:193-201.
• Bertini, E, Dionisi-Vici, C, Garavaglia, B, et al. Peripheral sensory-motor polyneuropathy, pigmentary retinopathy, and fatal cardiomyopathy in long-chain 3-hydroxy-acyl-CoA dehydrogenase deficiency. Eur J Pediatr. 1992; 151:121-126.
• Betz, RC, Schoser, BG, Kasper, D, et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet. 2001; 28:218-219.
• Bisceglia, L, Zoccolella, S, Torraco, A, et al. A new locus on 3p23-p25 for an autosomal-dominant limb-girdle muscular dystrophy, LGMD1H. Eur J Hum Genet. 2010; 18:636-641.
• Bohan, A and Peter, JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975; 292:344-347.
• Bohan, A and Peter, JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975; 292:403-407.
• Bohm, J, Chevessier, F, Maues De, PA, et al. Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. Am J Hum Genet. 2013; 92:271-278.
• Bolton, CF. Neuromuscular manifestations of critical illness. Muscle Nerve. 2005; 32:140-163.
• Bonne, G, Di Barletta, MR, Varnous, S, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 1999; 21:285-288.
• Bourteel, H, Vermersch, P, Cuisset, JM, et al. Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients. J Neurol Neurosurg Psychiatry. 2009; 80:1405-1408.
• Brais, B. Oculopharyngeal muscular dystrophy: a polyalanine myopathy. Curr Neurol Neurosci Rep. 2009; 9:76-82.
• Brais, B, Bouchard, JP, Xie, YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet. 1998; 18:164-167.
• Brunner, HG, Bruggenwirth, HT, Nillesen, W, et al. Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet. 1993; 53:1016-1023.
• Buchbinder, R, Forbes, A, Hall, S, et al. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med. 2001; 134:1087-1095.
• Burnett, BG, Munoz, E, Tandon, A, et al. Regulation of SMN protein stability. Mol Cell Biol. 2009; 29:1107-1115.
• Bushby, KM. Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC Consortium on Limb-Girdle Dystrophies. Neuromuscul Disord. 1995; 5:71-74.
• Butchbach, ME. Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases. Front Mol Biosci. 2016; 3:7.
• Cain, AJ, Michie, BA, Davis, BC, et al. Focal myositis of the sternocleidomastoid muscle. J Laryngol Otol. 1998; 112:687-689.
• Cao, H and Hegele, RA. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000; 9:109-112.
• Capoferri, G, Milani, GP, Ramelli, GP, et al. Sporadic acute benign calf myositis: Systematic literature review. Neuromuscul Disord. 2018; 28:443-449.
• Carlsson, L, Yu, JG, Moza, M, et al. Myotilin: a prominent marker of myofibrillar remodelling. Neuromuscul Disord. 2007; 17:61-68.
• Chabrol, B, Figarella-Branger, D, Coquet, M, et al. X-linked myopathy with excessive autophagy: a clinicopathological study of five new families. Neuromuscul Disord. 2001; 11:376-388.
• Chung, T, Christopher-Stine, L, Paik, JJ, et al. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve. 2015; 52:189-195.
• Cowling, BS, Cottle, DL, Wilding, BR, et al. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord. 2011; 21:237-251.
• Cullup, T, Lamont, PJ, Cirak, S, et al. Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement. Neuromuscul Disord. 2012; 22:1096-1104.
• Dalakas, MC and Hohlfeld, R. Polymyositis and dermatomyositis. Lancet. 2003; 362:971-982.
• Daxinger, L, Tapscott, SJ, and van der Maarel, SM. Genetic and epigenetic contributors to FSHD. Curr Opin Genet Dev. 2015; 33:56-61.
• De Bleecker, JL, De, PB, Aronica, E, et al. 205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands. Neuromuscul Disord. 2015; 25:268-272.
• De Bleecker, JL, Engel, AG, and Ertl, BB. Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol. 1996; 55:563-577.
• Deak, KL, Lemmers, RJ, Stajich, JM, et al. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4. Neurology. 2007; 68:578-582.
• Deng, J, Yu, J, Li, P, et al. Expansion of GGC Repeat in GIPC1 Is Associated with Oculopharyngodistal Myopathy. Am J Hum Genet. 2020; 106:793-804.
• Di Donato, S and Taroni, F. Disorder of Lipid Metabolism. In: Engel A, Franzini-Armstrong C, eds. Myology.3 ed. New York: McGrawHll, 2004:1587-1621.
• Dincer, P, Balci, B, Yuva, Y, et al. A novel form of recessive limb girdle muscular dystrophy with mental retardation and abnormal expression of alpha-dystroglycan. Neuromuscul Disord. 2003; 13:771-778.
• Dionisi-Vici, C, Garavaglia, B, Burlina, AB, et al. Hypoparathyroidism in mitochondrial trifunctional protein deficiency. J Pediatr. 1996; 129:159-162.
• Donkervoort, S, Chan, SHS, Hayes, LH, et al. Cytoplasmic body pathology in severe ACTA1-related myopathy in the absence of typical nemaline rods. Neuromuscul Disord. 2017; 27:531-536.
• Doppler, K, Knop, S, Einsele, H, et al. Sporadic late onset nemaline myopathy and immunoglobulin deposition disease. Muscle Nerve. 2013; 48:983-988.
• Dubowitz, V. Rigid spine syndrome: a muscle syndrome in search of a name. Proc R Soc Med. 1973; 66:219-220.
• Eisenberg, I, Avidan, N, Potikha, T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet. 2001; 29:83-87.
• Emery, AE and Dreifuss, FE. Unusual type of benign x-linked muscular dystrophy. J Neurol Neurosurg Psychiatry. 1966; 29:338-342.
• Emslie-Smith, AM and Engel, AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol. 1990; 27:343-356.
• Endo, Y, Noguchi, S, Hara, Y, et al. Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca(2)(+) channels. Hum Mol Genet. 2015; 24:637-648.
• Engel, AG and Selcen, D. Myofibrillar Myopathies. In: Engel AG, Franzini-Armstrong C, eds. Myology.3 ed. New York: McGraw-Hill, 2004:1187-1202.
• Engel, AG. Electron microscopic observations in thyrotoxic and corticosteroid-induced myopathies. Mayo Clin Proc. 1966a; 41:785-796.
• Engel, AG. Late-onset rod myopathy (a new syndrome?): light and electron microscopic observations in two cases. Mayo Clin Proc. 1966b; 41:713-741.
• Engel, AG, Gomez, MR, and Groover, RV. Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin Proc. 1971; 46:666-681.
• Eymard, B, Romero, NB, Leturcq, F, et al. Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology. 1997; 48:1227-1234.
• Falhammar, H, Thoren, M, and Calissendorff, J. Thyrotoxic periodic paralysis: clinical and molecular aspects. Endocrine. 2013; 43:274-284.
• Fanin, M, Nascimbeni, AC, and Angelini, C. hoinnsha Muscle protein analysis in the detection of heterozygotes for recessive limb girdle muscular dystrophy type 2B and 2E. Neuromuscul Disord. 2006; 16:792-799.
• Fardeau, M, Eymard, B, Mignard, C, et al. Chromosome 15-linked limb-girdle muscular dystrophy: clinical phenotypes in Reunion Island and French metropolitan communities. Neuromuscul Disord. 1996; 6:447-453.
• Feit, H, Silbergleit, A, Schneider, LB, et al. Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31. Am J Hum Genet. 1998; 63:1732-1742.
• Feldkotter, M, Schwarzer, V, Wirth, R, et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002; 70:358-368.
• Ferreiro, A, Ceuterick-de, GC, Marks, JJ, et al. Desmin-related myopathy with Mallory body-like inclusions is caused by mutations of the selenoprotein N gene. Ann Neurol. 2004; 55:676-686.
• Fiorentino, DF, Chung, LS, Christopher-Stine, L, et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1gamma. Arthritis Rheum. 2013; 65:2954-2962.
• Fischer, J, Lefevre, C, Morava, E, et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet. 2007; 39:28-30.
• Francis, A, Sunitha, B, Vinodh, K, et al. Novel TCAP mutation c.32C>A causing limb girdle muscular dystrophy 2G. PLoS One. 2014; 9:e102763.
• Frosk, P, Weiler, T, Nylen, E, et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet. 2002; 70:663-672.
• Furui, E, Fukushima, K, Sakashita, T, et al. Familial limb-girdle myasthenia with tubular aggregates. Muscle Nerve. 1997; 20:599-603.
• Geng, LN, Yao, Z, Snider, L, et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell. 2012; 22:38-51.
• Godfrey, C, Escolar, D, Brockington, M, et al. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann Neurol. 2006; 60:603-610.
• Goebel, HH. Desmin-related neuromuscular disorders. Muscle Nerve. 1995; 18:1306-1320.
• Goizet, C, Yaou, RB, Demay, L, et al. A new mutation of the lamin A/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia. J Med Genet. 2004; 41:e29.
• Hackman, P, Sarparanta, J, Lehtinen, S, et al. Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1. Ann Neurol. 2013; 73:500-509.
• Hagerman, RJ, Leehey, M, Heinrichs, W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001; 57:127-130.
• Hamanaka, K, Sikrova, D, Mitsuhashi, S, et al. Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy. Neurology. 2020; 94:e2441-e2447.
• Hamanaka, K, Goto, K, Arai, M, et al. Clinical, muscle pathological, and genetic features of Japanese facioscapulohumeral muscular dystrophy 2 (FSHD2) patients with SMCHD1 mutations. Neuromuscul Disord. 2016; 26:300-308.
• Hayashi, YK, Matsuda, C, Ogawa, M, et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest. 2009; 119:2623-2633.
• Hayashi, YK, Chou, FL, Engvall, E, et al. Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet. 1998; 19:94-97.
• Hayashi, YK, Mizuno, Y, Yoshida, M, et al. The frequency of patients with 50-kd dystrophin-associated glycoprotein (50DAG or adhalin) deficiency in a muscular dystrophy patient population in Japan: immunocytochemical analysis of 50DAG, 43DAG, dystrophin, and utrophin. Neurology. 1995; 45:551-554.
• Heffner, RR, Jr. and Barron, SA. Polymyositis beginning as a focal process. Arch Neurol. 1981; 38:439-442.
• Higuchi, I, Suehara, M, Iwaki, H, et al. Collagen VI deficiency in Ullrich's disease. Ann Neurol. 2001; 49:544.
• Hirano, M, Silvestri, G, Blake, DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology. 1994; 44:721-727.
• Hirano, M, Garcia-de-Yebenes, J, Jones, AC, et al. Mitochondrial neurogastrointestinal encephalomyopathy syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet. 1998; 63:526-533.
• Horvath, R, Kemp, JP, Tuppen, HA, et al. Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain. 2009; 132:3165-3174.
• Huang, YL, Chen, YJ, Lin, MW, et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol. 2009; 161:854-860.
• Ianuzzo, D, Patel, P, Chen, V, et al. Thyroidal trophic influence on skeletal muscle myosin. Nature. 1977; 270:74-76.
• Ichimura, Y, Matsushita, T, Hamaguchi, Y, et al. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis. 2012; 71:710-713.
• Illarioshkin, SN, Ivanova-Smolenskaya, IA, Greenberg, CR, et al. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy. Neurology. 2000; 55:1931-1933.
• Ishiura, H, Shibata, S, Yoshimura, J, et al. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet. 2019; 51:1222-1232.
• Izumi, R, Niihori, T, Aoki, Y, et al. Exome sequencing identifies a novel TTN mutation in a family with hereditary myopathy with early respiratory failure. J Hum Genet. 2013; 58:259-266.
• Jerusalem, F, Engel, AG, and Gomez, MR. Sarcotubular myopathy. A newly recognized, benign, congenital, familial muscle disease. Neurology. 1973; 23:897-906.
• Johnson, NE and Statland, JM. FSHD1 or FSHD2: That is the question: The answer: It's all just FSHD. Neurology. 2019; 92:881-882.
• Jungbluth, H and Gautel, M. Pathogenic mechanisms in centronuclear myopathies. Front Aging Neurosci. 2014; 6:339.
• Kalimo, H, Savontaus, ML, Lang, H, et al. X-linked myopathy with excessive autophagy: a new hereditary muscle disease. Ann Neurol. 1988; 23:258-265.
• Kastrup, A, Gdynia, HJ, Nagele, T, et al. Dropped-head syndrome due to steroid responsive focal myositis: a case report and review of the literature. J Neurol Sci. 2008; 267:162-165.
• Kaufman, LD, Kephart, GM, Seidman, RJ, et al. The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature. Arthritis Rheum. 1993; 36:1014-1024.
• Kayashima, T, Matsuo, H, Satoh, A, et al. Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE). J Hum Genet. 2002; 47:77-79.
• Keilland, E, Rupar, CA, Prasad, AN, et al. The expanding phenotype of MELAS caused by the m.3291T > C mutation in the MT-TL1 gene. Mol Genet Metab Rep. 2016; 6:64-69.
• Kennedy, WR, Alter, M, and Sung, JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968; 18:671-680.
• Kirschner, J, Brune, T, Wehnert, M, et al. p.S143F mutation in lamin A/C: a new phenotype combining myopathy and progeria. Ann Neurol. 2005; 57:148-151.
• Kitaguchi, T, Matsubara, S, Sato, M, et al. A missense mutation in the exon 8 of lamin A/C gene in a Japanese case of autosomal dominant limb-girdle muscular dystrophy and cardiac conduction block. Neuromuscul Disord. 2001; 11:542-546.
• Kley, RA, Hellenbroich, Y, van der Ven, PF, et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain. 2007; 130:3250-3264.
• Klinge, L, Dean, AF, Kress, W, et al. Late onset in dysferlinopathy widens the clinical spectrum. Neuromuscul Disord. 2008; 18:288-290.
• Knochel, JP and Moore, GE. Rhabdomyolysis in Malaria. N Engl J Med. 1993; 329:1206-1207.
• Kobayashi, K, Sasaki, J, Kondo-Iida, E, et al. Structural organization, complete genomic sequences and mutational analyses of the Fukuyama-type congenital muscular dystrophy gene, fukutin. FEBS Lett. 2001; 489:192-196.
• Kobayashi, Y, Fujimoto, T, Shiiki, H, et al. Focal eosinophilic myositis. Clin Rheumatol. 2001; 20:369-371.
• Korenyi-Both, A, Korenyi-Both, I, and Kayes, BC. Thyrotoxic myopathy. Pathomorphological observations of human material and experimentally induced thyrotoxicosis in rats. Acta Neuropathol. 1981; 53:237-248.
• Kowaljow, V, Marcowycz, A, Ansseau, E, et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord. 2007; 17:611-623.
• Krahn, M, Beroud, C, Labelle, V, et al. Analysis of the DYSF mutational spectrum in a large cohort of patients. Hum Mutat. 2009; 30:E345-E375.
• La Spada, AR, Wilson, EM, Lubahn, DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991; 352:77-79.
• Lamande, SR and Bateman, JF. Collagen VI disorders: Insights on form and function in the extracellular matrix and beyond. Matrix Biol. 2018; 71-72:348-367.
• Landon-Cardinal, O, Gallay, L, Dubourg, O, et al. Expanding the spectrum of HIV-associated myopathy. J Neurol Neurosurg Psychiatry. 2019.
• Larsson, L, Li, X, Edstrom, L, et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels. Crit Care Med. 2000; 28:34-45.
• Layzer, RB, Shearn, MA, and Satya-Murti, S. Eosinophilic polymyositis. Ann Neurol. 1977; 1:65-71.
• Le, TT, Pham, LT, Butchbach, ME, et al. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet. 2005; 14:845-857.
• Lefevre, C, Jobard, F, Caux, F, et al. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet. 2001; 69:1002-1012.
• Leigh, D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry. 1951; 14:216-221.
• Limaye, V, Bundell, C, Hollingsworth, P, et al. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy. Muscle Nerve. 2015; 52:196-203.
• Longman, C, Brockington, M, Torelli, S, et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet. 2003; 12:2853-2861.
• Lu, QL, Morris, GE, Wilton, SD, et al. Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J Cell Biol. 2000; 148:985-996.
• Maeda, MH, Tsuji, S, and Shimizu, J. Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain. 2012; 135:1767-1777.
• Malfatti, E, Birouk, N, Romero, NB, et al. Juvenile-onset permanent weakness in muscle phosphofructokinase deficiency. J Neurol Sci. 2012; 316:173-177.
• Mammen, AL, Chung, T, Christopher-Stine, L, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum. 2011; 63:713-721.
• Matsubara, S and Kitaguchi, T. Pathological changes of the myonuclear fibrous lamina and internal nuclear membrane in two cases of autosomal dominant limb-girdle muscular dystrophy with atrioventricular conduction disturbance (LGMD1B). Acta Neuropathol. 2004; 107:111-118.
• Matsubara, S. Polymyositis and dermatomyositis. In: Pamham M, ed. Compendium of Inflammatory Diseases.1 ed. Basel: Springer, 2016a:1-16.
• Matsubara, S, Shimizu, T, Komori, T, et al. Nuclear inclusions mimicking poly(A)-binding protein nuclear 1 inclusions in a case of inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia with a novel mutation in the valosin-containing protein gene. Neuromuscul Disord. 2016b; 26:436-440.
• Matsubara, S, Kondo, K, Miyamoto, K, et al. Early disintegration of myonuclear fibrous lamina in inclusion body myositis. Ultrastructural and immunohistochemical studies. Clin Exp Neuroimmunol 2016c; 7, 185-196.
• Matsubara, S, Bokuda, K, Asano, Y, et al. Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: ultrastructural and immunohistochemical studies. Neuromuscul Disord. 2018; 28:283-288.
• Matsubara, S, Takamori, M, Adachi, H, et al. Acute toxoplasma myositis: an immunohistochemical and ultrastructural study. Acta Neuropathol. 1990; 81:223-227.
• Matsubara, S, Okada, T, and Yoshida, M. Mitochondrial changes in acute myopathy after treatment of respiratory failure with mechanical ventilation (acute relaxant-steroid myopathy). Acta Neuropathol. 1994; 88:475-478.
• Matsubara, S, Mizuno, Y, Kitaguchi, T, et al. Fukuyama-type congenital muscular dystrophy: close relation between changes in the muscle basal lamina and plasma membrane. Neuromuscul Disord. 1999; 9:388-398.
• Matsubara, S, Kitaguchi, T, Isozaki, E, et al. Changes in the cytoskeletal proteins, sarcoplasmic reticulum, and capillaries in acute relaxant-steroid myopathy (ARSM) in contrast to the corticosteroid myopathy. Acta Neuropathol. 1999; 97:515-519.
• Melia, MJ, Kubota, A, Ortolano, S, et al. Limb-girdle muscular dystrophy 1F is caused by a microdeletion in the transportin 3 gene. Brain. 2013; 136:1508-1517.
• Merlini, L, Granata, C, Dominici, P, et al. Emery-Dreifuss muscular dystrophy. Report of five cases in a family and review of the literature. Muscle Nerve. 1986; 9, 481-485.
• Mescam-Mancini, L, Allenbach, Y, Hervier, B, et al. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis. Brain. 2015; 138:2485-2492.
• Mimaki, M, Hatakeyama, H, Komaki, H, et al. Reversible infantile respiratory chain deficiency: a clinical and molecular study. Ann Neurol. 2010; 68:845-854.
• Minetti, C, Sotgia, F, Bruno, C, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 1998; 18:365-368.
• Modi, G. Cores in hypothyroid myopathy: a clinical, histological and immunofluorescence study. J Neurol Sci. 2000; 175:28-32.
• Moghadaszadeh, B, Desguerre, I, Topaloglu, H, et al. Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36. Am J Hum Genet. 1998; 62:1439-1445.
• Moghadaszadeh, B, Topaloglu, H, Merlini, L, et al. Genetic heterogeneity of congenital muscular dystrophy with rigid spine syndrome. Neuromuscul Disord. 1999; 9:376-382.
• Mohassel, P and Mammen, AL. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle Nerve. 2013; 48:477-483.
• Muller, TJ, Kraya, T, Stoltenburg-Didinger, G, et al. Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol. 2014; 76:669-680.
• Munteanu, I, Ramachandran, N, Mnatzakanian, GN, et al. Fine-mapping the gene for X-linked myopathy with excessive autophagy. Neurology. 2008; 71:951-953.
• Muntoni, F, Torelli, S, and Brockington, M. Muscular dystrophies due to glycosylation defects. Neurotherapeutics. 2008; 5:627-632.
• Murakami, T, Hayashi, YK, Noguchi, S, et al. Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol. 2006; 60:597-602.
• Naito, E, Ito, M, Yokota, I, et al. Thiamine-responsive pyruvate dehydrogenase deficiency in two patients caused by a point mutation (F205L and L216F) within the thiamine pyrophosphate binding region. Biochim Biophys Acta. 2002; 1588:79-84.
• Nakano, S, Engel, AG, Waclawik, AJ, et al. Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases. J Neuropathol Exp Neurol. 1996; 55:549-562.
• Needham, M, Fabian, V, Knezevic, W, et al. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord. 2007; 17:194-200.
• Nigro,V, Savarese. Genetic basis of limb-girdle muscular dystrophies. The 2014 update. Acta Myol. 2014; 33:1-12.
• Nishigaki, Y, Bonilla, E, Shanske, S, et al. Exercise-induced muscle ”burning,” fatigue, and hyper-CKemia: mtDNA T10010C mutation in tRNA(Gly). Neurology. 2002; 58:1282-1285.
• Nishino, I, Fu, J, Tanji, K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature. 2000; 406:906-910.
• Nishino, I, Spinazzola, A, and Hirano, M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999; 283:689-692.
• Novelli, G, Muchir, A, Sangiuolo, F, et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet. 2002; 71:426-431.
• Oda, K, Nakaseko, C, Ozawa, S, et al. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant. 2009; 43:159-167.
• Okamoto, Y, Higuchi, I, Sakiyama, Y, et al. A new mitochondria-related disease showing myopathy with episodic hyper-creatine kinase-emia. Ann Neurol. 2011; 70:486-492.
• Olive, M, Goldfarb, LG, Shatunov, A, et al. Myotilinopathy: refining the clinical and myopathological phenotype. Brain. 2005; 128:2315-2326.
• Osborne, RJ, Welle, S, Venance, SL, et al. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology. 2007; 68:569-577.
• Pan, TC, Zhang, RZ, Sudano, DG, et al. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet. 2003; 73:355-369.
• Parker, P, Chao, NJ, Ben-Ezra, J, et al. Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine (Baltimore). 1996; 75:279-285.
• Pegoraro, E, Cepollaro, F, Prandini, P, et al. Integrin alpha 7 beta 1 in muscular dystrophy/myopathy of unknown etiology. Am J Pathol. 2002; 160:2135-2143.
• Purevsuren, J, Fukao, T, Hasegawa, Y, et al. Clinical and molecular aspects of Japanese patients with mitochondrial trifunctional protein deficiency. Mol Genet Metab. 2009; 98:372-377.
• Quinzii, CM, Vu, TH, Min, KC, et al. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein. Am J Hum Genet. 2008; 82:208-213.
• Raheem, O, Olufemi, SE, Bachinski, LL, et al. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2. Am J Pathol. 2010; 177:3025-3036.
• Ricker, K, Koch, MC, Lehmann-Horn, F, et al. Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology. 1994; 44:1448-1452.
• Ricker, K, Koch, MC, Lehmann-Horn, F, et al. Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol. 1995; 52:25-31.
• Sacconi, S, Salviati, L, and Desnuelle, C. Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta. 2015; 1852:607-614.
• Sacconi, S, Briand-Suleau, A, Gros, M, et al. FSHD1 and FSHD2 form a disease continuum. Neurology. 2019; 92:e2273-e2285.
• Salmikangas, P, Mykkanen, OM, Gronholm, M, et al. Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy. Hum Mol Genet. 1999; 8:1329-1336.
• Sarparanta, J, Jonson, PH, Golzio, C, et al. Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy. Nat Genet. 2012; 44:450-452.
• Schaefer, J, Jackson, S, Dick, DJ, et al. Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect. Ann Neurol. 1996; 40:597-602.
• Schakman, O, Gilson, H, and Thissen, JP. Mechanisms of glucocorticoid-induced myopathy. J Endocrinol. 2008; 197:1-10.
• Schessl, J, Goemans, NM, Magold, AI, et al. Predominant fiber atrophy and fiber type disproportion in early ullrich disease. Muscle Nerve. 2008; 38:1184-1191.
• Schessl, J, Feldkirchner, S, Kubny, C, et al. Reducing body myopathy and other FHL1-related muscular disorders. Semin Pediatr Neurol. 2011; 18:257-263.
• Schroder, R, Reimann, J, Salmikangas, P, et al. Beyond LGMD1A: myotilin is a component of central core lesions and nemaline rods. Neuromuscul Disord. 2003; 13:451-455.
• Schweiger, M, Lass, A, Zimmermann, R, et al. Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am J Physiol Endocrinol Metab. 2009; 297:E289-E296.
• Seki, M, Uruha, A, Ohnuki, Y, et al. Inflammatory myopathy associated with PD-1 inhibitor. Journal of Autoimmunity. 2019; submitted.
• Selcen, D and Engel, AG. Mutations in myotilin cause myofibrillar myopathy. Neurology. 2004; 62:1363-1371.
• Selcen, D and Engel, AG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol. 2005; 57:269-276.
• Selcen, D, Muntoni, F, Burton, BK, et al. Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol. 2009; 65:83-89.
• Selcen, D. Myofibrillar myopathies. Neuromuscul Disord. 2011; 21:161-171.
• Selva-O'Callaghan, A, Trallero-Araguas, E, and Grau, JM. Eosinophilic myositis: an updated review. Autoimmun Rev. 2014; 13:375-378.
• Senderek, J, Garvey, SM, Krieger, M, et al. Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet. 2009; 84:511-518.
• Senderek, J, Muller, JS, Dusl, M, et al. Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. Am J Hum Genet. 2011; 88:162-172.
• Shieh, PB, Kudryashova, E, and Spencer, MJ. Limb-girdle muscular dystrophy 2H and the role of TRIM32. Handb Clin Neurol. 2011; 101:125-133.
• Sigurgeirsson, B, Lindelof, B, Edhag, O, et al. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med. 1992; 326:363-367.
• Sinagra, G, Di, LA, Brodsky, GL, et al. Current perspective new insights into the molecular basis of familial dilated cardiomyopathy. Ital Heart J. 2001; 2:280-286.
• Sone, J, Mori, K, Inagaki, T, et al. Clinicopathological features of adult-onset neuronal intranuclear inclusion disease. Brain. 2016; 139:3170-3186.
• Starling, A, Kok, F, Passos-Bueno, MR, et al. A new form of autosomal dominant limb-girdle muscular dystrophy (LGMD1G) with progressive fingers and toes flexion limitation maps to chromosome 4p21. Eur J Hum Genet. 2004; 12:1033-1040.
• Statland, JM and Tawil, R. Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions. Curr Opin Neurol. 2011; 24:423-428.
• Stenzel, W, Preusse, C, Allenbach, Y, et al. Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy. Neurology. 2015; 84:1346-1354.
• Stevens, AM, Sullivan, KM, and Nelson, JL. Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford). 2003; 42:34-39.
• Straub, V, Murphy, A, and Udd, B. 229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord. 2018; 28:702-710.
• Suzuki, S, Satoh, T, Sato, S, et al. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology (Oxford). 2008; 47:1539-1542.
• Taniguchi, K, Kobayashi, K, Saito, K, et al. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Hum Mol Genet. 2003; 12:527-534.
• Targoff, IN, Mamyrova, G, Trieu, EP, et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006; 54:3682-3689.
• Targoff, IN, Johnson, AE, and Miller, FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum. 1990; 33:1361-1370.
• Taylor, DA, Carroll, JE, Smith, ME, et al. Facioscapulohumeral dystrophy associated with hearing loss and Coats syndrome. Ann Neurol. 1982; 12:395-398.
• Taylor, WR and Prosser, DI. Occult ischemic necrosis of skeletal muscle. BMJ. 1990; 301:610.
• Toda, T and Kobayashi, K. Fukuyama-type congenital muscular dystrophy: the first human disease to be caused by an ancient retrotransposal integration. J Mol Med (Berl). 1999; 77:816-823.
• Tome, FM, Askanas, V, Engel, WK, et al. Nuclear inclusions in innervated cultured muscle fibers from patients with oculopharyngeal muscular dystrophy. Neurology. 1989; 39:926-932.
• Tome, FM, Evangelista, T, Leclerc, A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III. 1994; 317:351-357.
• Torella, A, Fanin, M, Mutarelli, M, et al. Next-generation sequencing identifies transportin 3 as the causative gene for LGMD1F. PLoS One. 2013; 8:e63536.
• Trallero-Araguas, E, Rodrigo-Pendas, JA, Selva-O'Callaghan, A, et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum. 2012; 64:523-532.
• Troyanov, Y, Targoff, IN, Tremblay, JL, et al. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005; 84:231-249.
• Tsujikawa, K, Hara, K, Muro, Y, et al. HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma. Neurology. 2016; 87:841-843.
• Tupler, R and Gabellini, D. Molecular basis of facioscapulohumeral muscular dystrophy. Cell Mol Life Sci. 2004; 61:557-566.
• Uruha, A, Noguchi, S, Hayashi, YK, et al. Hepatitis C virus infection in inclusion body myositis: A case-control study. Neurology. 2016; 86:211-217.
• Vainzof, M, Moreira, ES, Suzuki, OT, et al. Telethonin protein expression in neuromuscular disorders. Biochim Biophys Acta. 2002; 1588:33-40.
• Vicart, P, Caron, A, Guicheney, P, et al. A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 1998; 20:92-95.
• Vieira, NM, Naslavsky, MS, Licinio, L, et al. A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G). Hum Mol Genet. 2014; 23:4103-4110.
• Villanova, M, Caudai, C, Sabatelli, P, et al. Hepatitis C virus infection and myositis: a polymerase chain reaction study. Acta Neuropathol. 2000; 99:271-276.
• Viscomi, C and Zeviani, M. MtDNA-maintenance defects: syndromes and genes. J Inherit Metab Dis. 2017; 40:587-599.
• Wajner, M and Amaral, AU. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies. Biosci Rep. 2015; 36:e00281.
• Walton, JN and Nattrass, FJ. On the classification, natural history and treatment of myopathies. Brain 77, 169-231. 1954.
• Warabi, Y, Matsubara, S, Mizutani, T, et al. [Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection]. Rinsho Shinkeigaku. 2004; 44:609-614.
• Watts, GD, Wymer, J, Kovach, MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004; 36:377-381.
• Welander, L. Myopathia distalis tarda hereditaria; 249 examined cases in 72 pedigrees. Acta Med Scand Suppl. 1951; 265:1-124.
• Windpassinger, C, Schoser, B, Straub, V, et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet. 2008; 82:88-99.
• Wulff, JD, Lin, JT, and Kepes, JJ. Inflammatory facioscapulohumeral muscular dystrophy and Coats syndrome. Ann Neurol. 1982; 12:398-401.
• Yamamoto, T, Shibata, N, Saito, Y, et al. Functions of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in neuromuscular system and other somatic organs. Cent Nerv Syst Agents Med Chem. 2010; 10:169-179.
• Yamashita, S, Mori, A, Nishida, Y, et al. Clinicopathological features of the first Asian family having vocal cord and pharyngeal weakness with distal myopathy due to a MATR3 mutation. Neuropathol Appl Neurobiol. 2015; 41:391-398.
• Zahr, ZA and Baer, AN. Malignancy in myositis. Curr Rheumatol Rep. 2011; 13:208-215.